Pregnancy can trigger aHUS and complement-mediated TMA, complicating diagnosis due to symptom overlap with other thrombotic microangiopathies, being highlighted by two cases: one successfully managed with eculizumab after a CFI variant diagnosis and another with persistent complement activation postpartum despite negative genetic testing [123]. The gene discussed is CFI; the disease is Genetic thrombotic microangiopathy.